Subbu Nambi
Stock Analyst at Guggenheim
(4.94)
# 151
Out of 5,133 analysts
206
Total ratings
68.3%
Success rate
36.4%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintained: Buy | $212 → $150 | $114.22 | +31.33% | 11 | Nov 13, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $32 → $34 | $29.48 | +15.33% | 7 | Nov 10, 2026 | |
| BRKR Bruker | Reiterated: Buy | $72 | $60.33 | +19.34% | 13 | Nov 10, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $155 | $121.35 | +27.73% | 14 | Nov 9, 2026 | |
| WGS GeneDx Holdings | Reiterated: Buy | $83 | $51.87 | +60.02% | 10 | Nov 9, 2026 | |
| WAT Waters | Reiterated: Buy | $490 | $462.20 | +6.01% | 8 | Nov 3, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $92 | $75.89 | +21.23% | 13 | Nov 2, 2026 | |
| ILMN Illumina | Reiterated: Buy | $305 | $209.55 | +45.55% | 15 | Oct 29, 2026 | |
| NEOG Neogen | Reiterated: Buy | $14 | $11.19 | +25.11% | 10 | Oct 19, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $125 → $128 | $110.79 | +15.53% | 7 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $19 | $20.10 | -5.47% | 6 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $250 | $232.16 | +7.68% | 9 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $190 → $200 | $154.86 | +29.15% | 18 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $475 | $322.94 | +47.09% | 9 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $10.61 | +97.93% | 1 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $24.63 | +163.91% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.38 | +68.07% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.68 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $34.50 | +36.23% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $15.86 | -18.03% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.86 | -10.94% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $166.52 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.97 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.54 | n/a | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $157.02 | n/a | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €287.10 | n/a | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $23.96 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.68 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.10 | n/a | 2 | Feb 23, 2025 |
Twist Bioscience
Nov 13, 2026
Maintained: Buy
Price Target: $212 → $150
Current: $114.22
Upside: +31.33%
Adaptive Biotechnologies
Nov 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $29.48
Upside: +15.33%
Bruker
Nov 10, 2026
Reiterated: Buy
Price Target: $72
Current: $60.33
Upside: +19.34%
GRAIL
Nov 9, 2026
Reiterated: Buy
Price Target: $155
Current: $121.35
Upside: +27.73%
GeneDx Holdings
Nov 9, 2026
Reiterated: Buy
Price Target: $83
Current: $51.87
Upside: +60.02%
Waters
Nov 3, 2026
Reiterated: Buy
Price Target: $490
Current: $462.20
Upside: +6.01%
Tempus AI
Nov 2, 2026
Reiterated: Buy
Price Target: $92
Current: $75.89
Upside: +21.23%
Illumina
Oct 29, 2026
Reiterated: Buy
Price Target: $305
Current: $209.55
Upside: +45.55%
Neogen
Oct 19, 2026
Reiterated: Buy
Price Target: $14
Current: $11.19
Upside: +25.11%
BillionToOne
Oct 1, 2026
Reiterated: Buy
Price Target: $125 → $128
Current: $110.79
Upside: +15.53%
Oct 1, 2026
Reiterated: Buy
Price Target: $16 → $19
Current: $20.10
Upside: -5.47%
Oct 1, 2026
Reiterated: Buy
Price Target: $200 → $250
Current: $232.16
Upside: +7.68%
Oct 1, 2026
Reiterated: Buy
Price Target: $190 → $200
Current: $154.86
Upside: +29.15%
Oct 1, 2026
Reiterated: Buy
Price Target: $360 → $475
Current: $322.94
Upside: +47.09%
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $10.61
Upside: +97.93%
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $24.63
Upside: +163.91%
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $2.38
Upside: +68.07%
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.68
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $47
Current: $34.50
Upside: +36.23%
May 7, 2026
Reiterated: Buy
Price Target: $13
Current: $15.86
Upside: -18.03%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $7.86
Upside: -10.94%
Feb 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $166.52
Upside: -
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.97
Upside: -
Oct 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $16.54
Upside: n/a
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $157.02
Upside: n/a
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €287.10
Upside: n/a
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $23.96
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $5.68
Upside: n/a
Feb 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $59.10
Upside: n/a